Scientists review the biological role of protein kinase C (PKC) isozymes in non-small cell lung cancer through extensive analysis of cell-line-based studies to better understand the rationale for PKC inhibition.
[International Journal of Molecular Sciences]
7753456
{7753456:8IIV6PSJ}
apa
50
1
162976
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-e6bf0ecb6816e46668c8672550b0da6f%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%228IIV6PSJ%22%2C%22library%22%3A%7B%22id%22%3A7753456%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Sadeghi%20et%20al.%22%2C%22parsedDate%22%3A%222021-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ESadeghi%2C%20M.%20M.%2C%20Salama%2C%20M.%20F.%2C%20%26amp%3B%20Hannun%2C%20Y.%20A.%20%282021%29.%20Protein%20Kinase%20C%20as%20a%20Therapeutic%20Target%20in%20Non-Small%20Cell%20Lung%20Cancer.%20%3Ci%3EInternational%20Journal%20of%20Molecular%20Sciences%3C%5C%2Fi%3E%2C%20%3Ci%3E22%3C%5C%2Fi%3E%2811%29%2C%205527.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fijms22115527%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fijms22115527%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D7753456%26amp%3Bitem_key%3D8IIV6PSJ%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Protein%20Kinase%20C%20as%20a%20Therapeutic%20Target%20in%20Non-Small%20Cell%20Lung%20Cancer%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mohammad%20Mojtaba%22%2C%22lastName%22%3A%22Sadeghi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mohamed%20F.%22%2C%22lastName%22%3A%22Salama%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yusuf%20A.%22%2C%22lastName%22%3A%22Hannun%22%7D%5D%2C%22abstractNote%22%3A%22Driver-directed%20therapeutics%20have%20revolutionized%20cancer%20treatment%2C%20presenting%20similar%20or%20better%20efficacy%20compared%20to%20traditional%20chemotherapy%20and%20substantially%20improving%20quality%20of%20life.%20Despite%20significant%20advances%2C%20targeted%20therapy%20is%20greatly%20limited%20by%20resistance%20acquisition%2C%20which%20emerges%20in%20nearly%20all%20patients%20receiving%20treatment.%20As%20a%20result%2C%20identifying%20the%20molecular%20modulators%20of%20resistance%20is%20of%20great%20interest.%20Recent%20work%20has%20implicated%20protein%20kinase%20C%20%28PKC%29%20isozymes%20as%20mediators%20of%20drug%20resistance%20in%20non-small%20cell%20lung%20cancer%20%28NSCLC%29.%20Importantly%2C%20previous%20findings%20on%20PKC%20have%20implicated%20this%20family%20of%20enzymes%20in%20both%20tumor-promotive%20and%20tumor-suppressive%20biology%20in%20various%20tissues.%20Here%2C%20we%20review%20the%20biological%20role%20of%20PKC%20isozymes%20in%20NSCLC%20through%20extensive%20analysis%20of%20cell-line-based%20studies%20to%20better%20understand%20the%20rationale%20for%20PKC%20inhibition.%20PKC%20isoforms%20%5Cu03b1%2C%20%5Cu03b5%2C%20%5Cu03b7%2C%20%5Cu03b9%2C%20%5Cu03b6%20upregulation%20has%20been%20reported%20in%20lung%20cancer%2C%20and%20overexpression%20correlates%20with%20worse%20prognosis%20in%20NSCLC%20patients.%20Most%20importantly%2C%20PKC%20isozymes%20have%20been%20established%20as%20mediators%20of%20resistance%20to%20tyrosine%20kinase%20inhibitors%20in%20NSCLC.%20Unfortunately%2C%20however%2C%20PKC-directed%20therapeutics%20have%20yielded%20unsatisfactory%20results%2C%20likely%20due%20to%20a%20lack%20of%20specific%20evaluation%20for%20PKC.%20To%20achieve%20satisfactory%20results%20in%20clinical%20trials%2C%20predictive%20biomarkers%20of%20PKC%20activity%20must%20be%20established%20and%20screened%20for%20prior%20to%20patient%20enrollment.%20Furthermore%2C%20tandem%20inhibition%20of%20PKC%20and%20molecular%20drivers%20may%20be%20a%20potential%20therapeutic%20strategy%20to%20prevent%20the%20emergence%20of%20resistance%20in%20NSCLC.%22%2C%22date%22%3A%222021%5C%2F1%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.3390%5C%2Fijms22115527%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.mdpi.com%5C%2F1422-0067%5C%2F22%5C%2F11%5C%2F5527%22%2C%22deleted%22%3A1%2C%22collections%22%3A%5B%2243ZBJFKZ%22%5D%2C%22dateModified%22%3A%222021-06-03T19%3A09%3A18Z%22%7D%7D%5D%7D
Sadeghi, M. M., Salama, M. F., & Hannun, Y. A. (2021). Protein Kinase C as a Therapeutic Target in Non-Small Cell Lung Cancer. International Journal of Molecular Sciences, 22(11), 5527. https://doi.org/10.3390/ijms22115527 Cite
